Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
As of today (2026-09-13), 2seventy bio's share price is MXN170.00. 2seventy bio's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was MXN81.21. Hence, 2seventy bio's Price to Tangible Book Ratio of today is 2.09.
The historical rank and industry rank for 2seventy bio's Price-to-Tangible-Book or its related term are showing as below:
MEX:TSVT's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 3.25 * Ranked among companies with meaningful Price-to-Tangible-Book only.
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
2seventy bio Price-to-Tangible-Book Related Terms
2seventy bio Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for 2seventy bio's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:TSVT vs ALMS, TERN, CRVS: Price-to-Tangible-Book Comparison
For the Biotechnology subindustry, 2seventy bio's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
2seventy bio Price-to-Tangible-Book vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 2seventy bio's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where 2seventy bio's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
2seventy bio (MEX:TSVT) has a Price-to-Tangible-Book of 2.09 as of Sep. 13, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on 2seventy bio and its competitors.
Is 2seventy bio's Price-to-Tangible-Book too high?
2seventy bio's current Price-to-Tangible-Book is 2.09. The Biotechnology industry median Price-to-Tangible-Book is 3.25. 2seventy bio's value of 2.09 is 35.7% below this industry median. Overall, 2seventy bio has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does 2seventy bio's Price-to-Tangible-Book compare to ALMS and TERN?
2seventy bio's Price-to-Tangible-Book of 2.09 can be compared against companies in the Biotechnology industry. The industry median Price-to-Tangible-Book is 3.25. 2seventy bio's value of 2.09 is 35.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Biotechnology company?
The median Price-to-Tangible-Book among Biotechnology companies is 3.25, based on 1,136 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 2seventy bio's current Price-to-Tangible-Book of 2.09 is 35.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on 2seventy bio and its competitors. For the Biotechnology industry, the median Price-to-Tangible-Book is 3.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 2seventy bio's current Price-to-Tangible-Book is 2.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 2seventy bio stock overvalued right now?
2seventy bio (MEX:TSVT) has a current Price-to-Tangible-Book of 2.09. The current Price-to-Tangible-Book is 2.09 and 35.7% below the Biotechnology industry median of 3.25. 2seventy bio's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For 2seventy bio (MEX:TSVT), the current Price-to-Tangible-Book is 2.09 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment focusing on researching, developing and commercializing potentially transformative treatments for cancer.
9GF Score
Get the complete analysis for MEX:TSVT
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TSVT has been successfully added to your 
